Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.
Nadarajah
S
S
Division of Immunology and Allergy, Hospital for Sick Children, Toronto, Ontario, Canada.
Krafchik
B
B
Roifman
C
C
Horgan-Bell
C
C
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D003872:Dermatitis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone